Publication Cover
Archives of Andrology
Journal of Reproductive Systems
Volume 31, 1993 - Issue 3
36
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Concentrations of Vasoactive Intestinal Polypeptide in Corpus Cavernosum and Peripheral Venous Blood During Prostaglandin E1-Induced Erection

, , , &
Pages 217-222 | Published online: 09 Jul 2009

References

  • Adaikan P G., Kottegoda S R., Ratnam S S. Is vasoactive intestinal polypeptide the principle transmitter involved in human penile erection?. J Urol 1986; 135: 638–640
  • Aim P, Alumets J, Harkanson R, Sundler F. Peptidergic (vasoactive intestinal peptide) nerves in the genito-urinary tract. Neuroscience 1977; 2: 751–752
  • Crowe R, Lincoln J, Blacklay P F., Pryor J P., Lumley J SP, Burnstock G. Vasoactive intestinal polypeptide-like immunoreactive nerves in diabetic penis. Diabetes 1983; 32: 1075–1077
  • Dixson A F., Kendrick K M., Blank M A., Bloom S R. Effects of tactile and electrical stimuli upon release of vasoactive intestinal polypeptide in the mammalian penis. J Endocrinol 1984; 100: 249–252
  • Fahrenkrug J, Schaffalitsky de Muckadell O B. Distribution of vasoactive intestinal polypeptide (VIP) in the porcine central nervous system. J Neurochem 1978; 31: 1445–1451
  • Fahrenkrug J, Schaffalitzky de Muckadell O B. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med 1977; 89: 1379–1388
  • Gerstenberg T C., Metz P, Ottesen B, Fahrenkrug J. Intracavernous self-injection with vasoactive intestinal peptide and phentolamine in the management of erectile failure. J Urol 1992; 147: 1277–1279
  • Goldstein I, Krane R J., Ottesen B, Fahrenkrug J, Wagner G. Changes in corporal vasoactive intestinal polypeptide (VIP) concentration following pelvic nerve stimulation. J Urol 1985; 133: 218A
  • Gozes I, Brenneman D E. VIP: molecular biology and neurobiological function. Mol Neurobiolo 1989; 3: 201–236
  • Gu J, Lazarides M, Pryor J P., Blank M A., Polak J M., Morgan R, Marangos P J., Bloom S R. Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent men. Lancet 1984; 8398: 315–317
  • Juenemann K P., Lue T F., Luo J A., Jadallah S A., Nunes L L., Tanagho E A. The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: a combined in vivo and immunohistochemical study. J Urol 1987; 138: 871–877
  • Kiely E A., Blank M A., Bloom S R., Williams G. Studies on intracavemosal VIP levels during pharmacologically induced penile erections. Br J Urol 1987; 59: 334
  • Kiely E A., Bloom S R., Williams G. Penile response to intracavemosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. Br J Urol 1989; 64: 191–194
  • Larsson L I., Fahrenkrug J, Schaffalitzky de Muckadell O B. Occurrence of nerves containing vasoactive intestinal polypeptide immunoreactivity in the male genital tract. Life Sci 1977; 21: 503–508
  • Lincoln J, Crowe R, Blacklay P F., Pryor J P., Lumley J SP, Burnstock G. Changes in the vipergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and nondiabetic impotent males. J Urol 1987; 137: 1053–1059
  • Ottesen B, Wagner G, Virag R, Fahrenkrug J. Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter. BMJ 1984; 288: 9–11
  • Polak J M., Bloom S R. Peripheral localization of regulatory peptides as a clue to their function. J Histochem Cytochem 1980; 28: 918–924
  • Roy J B., Said S I., Paul S, Parry W L. Decreased VIP immunoreactivity in cavernous tissue from men with organic erectile failure. Surg Forum 1986; 37: 638–639
  • Roy J B., Petrone R L., Said S I. A clinical trial of intracanernous vasoactive intestinal peptide to induce penile erection. J Urol 1990; 143: 302–304
  • Said S I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 1970; 169: 1217–1218
  • Shirai M, Maki A, Takanami M, Ando K, Nakamura K, Yanaihara N, Yanaihara C, Iguchi K, Fujita T, Iwanaga T. Content and distribution of vasoactive intestinal polypeptide (VIP) in cavernous tissue of human penis. Urology 1990; 35: 360–363
  • Sjöstrand N O., Klinge E, Himberg J J. Effects of VIP and other putative neurotransmitters on smooth muscle effectors of penile erection. Acta Physiol Scand 1981; 113: 403–405
  • Steers W D., McConnell J, Benson G S. Anatomical localization and some pharmacological effects of vasoactive intestinal polypeptide in human and monkey corpus cavernosum. J Urol 1984; 132: 1048–1053
  • Vaalasti A, Tainio H, Pelto-Huikko M, Hervonen A. Light and electron microscope demonstration of VIP- and enkephalin-immunoreactive nerves in the human male genitourinary tract. Anat Rec 1986; 215: 21–27
  • Virag R, Ottesen B, Fahrenkrug J, Levy C, Wagner G. Vasoactive intestinal polypeptide release during penile erection in man. Lancet 1982; 8308: 1166
  • Willis E, Ottesen B, Wagner G, Sundler F, Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol Scand 1981; 113: 545–547

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.